Frequency of Cirrhotic Cardiomyopathy Among Patients with Liver Cirrhosis
DOI:
https://doi.org/10.70749/ijbr.v3i2.637Keywords:
Cirrhotic Cardiomyopathy, Liver Cirrhosis, Cardiac DysfunctionAbstract
Introduction: Patients with liver cirrhosis may develop cirrhotic cardiomyopathy (CCM), a disorder marked by a compromised cardiac response to stress. Because of its mild clinical appearance and comorbidity with other signs of liver disease, it often remains undetected. The purpose of this study is to evaluate the clinical importance of CCM and ascertain its prevalence in cirrhotic individuals. Methods: Study was conducted from July 2024 to December 2024. Purposive sampling was used to identify 200 liver cirrhosis patients from a tertiary care hospital in Karachi, Pakistan, for this qualitative study. Semi-structured, in-depth interviews were used to gather data, and thematic analysis was used to find recurrent themes in the participants' CCM experiences. Results: According to the study, patients with cirrhosis that lasted one to three years had the highest prevalence of CCM symptoms, with fatigue and dyspnea being the most often reported symptoms. Significant abnormalities were revealed by echocardiography, including an enlarged left atrium and left ventricular diastolic dysfunction. The majority of individuals reported symptoms after 1-3 years of cirrhosis, and the frequency of CCM symptoms rose with the length of cirrhosis. Conclusion: The prevalence of cirrhotic cardiomyopathy (CCM) in clinical practice is significant, as highlighted by this study. Findings emphasize the link between cirrhosis duration and CCM onset, with myocardial dysfunction worsening as cirrhosis progresses. Common symptoms include peripheral edema, fatigue, and dyspnea. Echocardiography often reveals left atrial enlargement and ventricular diastolic dysfunction. Early detection and cardiovascular monitoring, especially in decompensated cirrhosis, can reduce morbidity and mortality through timely intervention.
Downloads
References
Zardi, E.M., et al. (2010) Cirrhotic cardiomyopathy. Journal of the American College of Cardiology, 56, 539- 549. http://dx.doi.org/10.1016/j.jacc.2009.12.075
Al Hamoudi, W., & Lee, S. S. (2006). Cirrhotic cardiomyopathy. Annals of Hepatology, 5(3), 132-139. https://www.medigraphic.com/pdfs/hepato/ah-2006/ah063b.pdf
Baik, S.K., Fouad, T.R. & Lee, S.S. (2007) Cirrhotic cardiomyopathy. Orphanet Journal of Rare Diseases, 2, 15. http://dx.doi.org/10.1186/1750-1172-2-15
Fourlas, C. A., & Alexopoulou, A. A. (2004). Cirrhotic cardiomyopathy. Hellenic J Cardiol, 45, 114-20. https://www.hellenicjcardiol.org/archive/full_text/2004/2/2004_2_114.pdf
LIU, H., SONG, D., & LEE, SS (2002). Cardiomyopathy and cirrhosis. Clinical and Biological Gastroenterology , 26 (10), 842-847. http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13979013
Henriksen, J. H., Bendtsen, F., Hansen, E. F. & Møller, S. (2004) Acute non-selective beta-adrenergic blockade re- duces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis. Journal of Hepatology, 40, 239-246. http://dx.doi.org/10.1016/j.jhep.2003.10.026
Grose, R.D., Noan, J., Dillon, J.F., Errington, M., et al. (1995) Exercise induced let ventricular dysfunction in alcoholic and non alcoholic cirrhosis. Journal of Hepa- tology, 22, 326-332. http://dx.doi.org/10.1016/0168-8278(95)80286-X
Wong, F., et al. (2001) The cardiac response to exercise in cirrhosis. Gut, 49, 268-275. http://dx.doi.org/10.1136/gut.49.2.268
Murray, J.G., Dawson, A.M. and Sherlock, S. (1958) Cir- culatory changes in chronic liver disease. American Jour- nal of Medicine, 24, 358-367. http://dx.doi.org/10.1016/0002-9343(58)90322-X
Ma, Z. and Lee, S.S. (1996) Cirrhotic cardiomyopathy: Getting to the heart of the matter. Hepatology, 24, 451- 459. http://dx.doi.org/10.1002/hep.510240226
Liu, H. and Lee, S.S. (1999) Cardiopulmonary dysfunc- tion in cirrhosis. Journal of Gastroenterology and Hepa- tology, 14, 600-608. http://dx.doi.org/10.1046/j.1440-1746.1999.01920.x
Grose, R. D., Nolan, J., Dillon, J. F., Errington, M., Hannan, W. J., Bouchier, I. A. D., & Hayes, P. C. (1995). Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. Journal of Hepatology, 22(3), 326–332. https://doi.org/10.1016/0168-8278(95)80286-x
Finucci, G., Desideri, A., Sacerdoti, D., Bolognesi, M., Merkel, C., Angeli, P., & Gatta, A. (1996). Left Ventricular Diastolic Function in Liver Cirrhosis. Scandinavian Journal of Gastroenterology, 31(3), 279–284. https://doi.org/10.3109/00365529609004879
Pozzi, M., Carugo, S., Boari, G. I. U. S. E. P. P. E., Pecci, V., de Ceglia, S. E. R. G. I. O., Maggiolini, S., ... & Mancia, G. (1997). Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology, 26(5), 1131-1137. https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.510260507
WONG, F., LIU, P., LILLY, L., BOMZON, A., & BLENDIS, L. (1999). Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clinical Science, 97(3), 259-267. https://doi.org/10.1042/cs0970259
Wong, F., Girgrah, N., Graba, J., Allidina, Y., Liu, P., & Blendis, L. (2001). The cardiac response to exercise in cirrhosis. Gut, 49(2), 268-275. https://doi.org/10.1136/gut.49.2.268
Abelmann, W. H., Kowalski, H. J., & McNeely, W. F. (1955). The hemodynamic response to exercise in patients with laennec's cirrhosis 1. Journal of Clinical Investigation, 34(5), 690-695. https://doi.org/10.1172/jci103120
Kim, M. Y., Baik, S. K., Won, C. S., Park, H. J., Jeon, H. K., Hong, H. I., Kim, J. W., Kim, H. S., Kwon, S. O., Kim, J. Y., Yoo, B. S., & Lee, S. H. (2010). Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis. The Korean Journal of Hepatology, 16(4), 376. https://doi.org/10.3350/kjhep.2010.16.4.376
Liu, H. (2006). Cardiac and vascular changes in cirrhosis: Pathogenic mechanisms. World Journal of Gastroenterology, 12(6), 837. https://doi.org/10.3748/wjg.v12.i6.837
Donovan, C. L., Marcovitz, P. A., Punch, J. D., Bach, D. S., Brown, K. A., Lucey, M. R., & Armstrong, W. F. (1996). Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation, 61(8), 1180-1188. https://doi.org/10.1097/00007890-199604270-00011
Myers, R. P., & Lee, S. S. (2000). Cirrhotic cardiomyopathy and liver transplantation. Liver Transplantation, 6(Supplement 1), S44-S52. https://doi.org/10.1002/lt.500060510
Kempler, P., Szalay, F., Varadi, A., Keresztes, K., Kadar, E., Tanczos, E., & Petrik, J. (1993). Prolongation of the QTc-interval reflects the severity of autonomic neuropathy in primary biliary cirrhosis and in other non-alcoholic liver diseases. Zeitschrift fur Gastroenterologie, 31, 96-98. https://europepmc.org/article/med/7483730
Bernardi, M., Calandra, S., Colantoni, A., Trevisani, F., Raimondo, M. L., Sica, G., Schepis, F., Mandini, M., Simoni, P., Contin, M., & Raimondo, G. (1998). Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology, 27(1), 28-34. https://doi.org/10.1002/hep.510270106
FINUCCI, G., LUNARDI, F., SACERDOTI, D., VOLPIN, R., BORTOLUZZI, A., BOMBONATO, G., ANGELI, P., & GATTA, A. (1998). Q-T interval prolongation in liver cirrhosis. Reversibility after Orthotopic liver transplantation. Japanese Heart Journal, 39(3), 321-329. https://doi.org/10.1536/ihj.39.321
Blendis, L., & Wong, F. (2000). Is there a cirrhotic cardiomyopathy? The American Journal of Gastroenterology, 95(11), 3026-3028. https://doi.org/10.1111/j.1572-0241.2000.03249.x
Navasa, M. (1993). Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology, 17(3), 355-360. https://doi.org/10.1016/0270-9139(93)90044-n
Henriksen, J. H., Bendtsen, F., Hansen, E. F., & Møller, S. (2004). Acute non-selective β-adrenergic blockade reduces prolonged frequency-adjusted Q–T interval (QTc) in patients with cirrhosis. Journal of Hepatology, 40(2), 239-246. https://doi.org/10.1016/j.jhep.2003.10.026
Møller, S., & Henriksen, J. H. (2002). Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart, 87(1), 9-15. https://heart.bmj.com/content/87/1/9.short
Liu, H, Song, D, & Lee, S. S. (2017). Cirrhotic cardiomyopathy. Gastroenterol Clin North Am, 46(2), 345-365.
Wong, F. (2009). Cirrhotic cardiomyopathy. Hepatology international, 3(1), 294-304. https://doi.org/10.1007/s12072-008-9109-7
Zardi, E., M., Zardi, D., M., Chin, D, et al. (2018). Cirrhotic cardiomyopathy in the critically ill patient. J Crit Care,47, 184-190.
Nazar, A., Guevara, M., Sitges, M., et al. (2010). Left ventricular function in cirrhotic patients with and without ascites. J Hepatol, 52(3), 382-388.
Karagiannakis, D., S, Vlach, Giannakos., J, Anastasiadis, G, et al. (2020). Impact of cirrhotic cardiomyopathy on post-liver transplant outcomes. Transplant, 33(3), 269-278.
Wong, F., Girgrah, N., Graba, J., Allidina, Y., Liu, P., & Blendis, L. (2001). The cardiac response to exercise in cirrhosis. Gut, 49(2), 268-275. https://doi.org/10.1136/gut.49.2.268
Møller, S, Krag, A, Henriksen, J, H. (2011). Pathogenesis and hemodynamic characteristics of cirrhotic cardiomyopathy. J Hepatol, 54(4), 872-885.
Pozzi, M., Carugo, S., Boari, G. I. U. S. E. P. P. E., Pecci, V., de Ceglia, S. E. R. G. I. O., Maggiolini, S., ... & Mancia, G. (1997). Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology, 26(5), 1131-1137. https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.510260507
Torregrosa, M., Aguadé, S., Dos, L., Segura, R., Gónzalez, A., Evangelista, A., ... & Genescà, J. (2005). Cardiac alterations in cirrhosis: reversibility after liver transplantation. Journal of hepatology, 42(1), 68-74. https://doi.org/10.1016/j.jhep.2004.09.008
Donovan, C. L., Marcovitz, P. A., Punch, J. D., Bach, D. S., Brown, K., Lucey, M. R., & Armstrong, W. F. (1996). TWO-DIMENSIONAL AND DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN THE PREOPERATIVE ASSESSMENT OF PATIENTS WITH END-STAGE LIVER DISEASE PRIOR TO ORTHOTOPIC LIVER TRANSPLANTATION. 61(8), 1180–1188. https://doi.org/10.1097/00007890-199604270-00011
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
